Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06173505 |
Title | Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Xencor, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | POL | NLD | GRC | ESP | BEL |